Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for cognition and hippocampal inflammation in schizophrenia
NL-OMON38222Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of valaciclovir in schizophrenia, sponsored by University Medical Center Groningen. Primary endpoint: [11C]-PK11195 hippocampal binding potential. Started Apr 2011; status: active, not recruiting.
02
Drugs
valaciclovir
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NL-OMON38222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38222.